Defective and Dangerous Medication Lawsuits
Drug manufacturers have a duty to make sure that medications they sell are not unreasonably dangerous and contain sufficient warnings about dangerous side effects so that physicians and patients can evaluate the risks and benefits before taking the medication. In many cases pharmaceutical companies fail to take simple steps to protect consumers when they place profits before people’s safety.
Side effect lawsuits are investigated nationwide for users of the following medications who suffered an injury. To review a potential case for yourself, a friend or family member, request a free consultation and claim evaluation.
Abilify (aripiprazole) was approved by the FDA in 2002, for the treatment of a number of psychological problems, including schizophrenia, bipolar disorder, depression and autism in adults and children. Many users of Abilify have reported side effects such as gambling addictions, unusual sexual behavior, compulsive shopping and other impulsive activities. Abilify can also can an increased risk of diabetes in children.
Actemra (tocilizumab) is a blockbuster rheumatoid arthritis drug introduced by Roche in January 2010. Similar drugs contained strong warnings about the cardiovascular risks and other health problems, Actemra warnings did not indicate that users may experience a heart attack, stroke, heart failure, lung disease, pancreatitis or other serious side effects. As a result, many doctors and patients were falsely led to believe that Actemra was safer, which does not appear to be the case.
Side effects of Actos, a popular type 2 diabetes medication, have been linked to an increased occurrence of bladder cancer.
Many users have experienced permanent damage to internal organs and a great deal of pain as a result of using the popular acne medication Accutane. Potential side effects may include Inflammatory Bowel Disease (IBD), Ulcerative Colitis, and Crohn’s Disease.
Side effects of Levaquin, Avelox, Cipro and other fluoroquinolone antibiotics have been linked to a risk of aortic dissection, aortic aneurysms and permanent nerve damage, known as peripheral neuropathy.
Side effects of Benicar, along with other popular blood pressure medications (Azor, Tribenzor) may cause users to suffer chronic diarrhea and other gastrointestinal problems. This can lead to drastic weight loss, malnutrition and other complications.
Crestor (rosuvastatin) is a blockbuster cholesterol drug sold by AstraZeneca, which has been shown to increase the risk of adult onset (type II) diabetes. Inadequate warnings were provided for years about the link between Crestor and diabetes.
Depakote, which was approved in 1983, is used to treat epilepsy and, in some cases, depression. However, use Depakote during pregnancy may result in severe birth defects including autism, malformed limbs, spina bifida, cleft-palate and other severe health problems.
Byetta, Victoza, Januvia and Janumet are all type II diabetes medications that are part of a class of drugs known as incretin mimetics. Use of the drugs has been linked to a risk of pancreatitis, which may cause some users to develop pancreatic cancer.
Fresenius Medical Care is the largest provider of dialysis services and products in the world. In 2012, it was discovered that Granuflo and NaturaLyte dialysis treatments may cause users to suffer sudden cardiac arrest, heart attack or death.
Diflucan (fluconazole) is the first of a relatively new subclass of anti-fungal medications, which is used for treatment of certain kinds of yeast infections and meningitis caused by a type of fungus. Diflucan side effects have been linked to an increased risk of serious and potentially life-threatening health problems and birth defects for babies when high doses of the medication are used during pregnancy.
Effexor (venlafaxine) is an antidepressant manufactured and sold by Pfizer, and is one of the most widely prescribed SSRIs. Studies show that women who have taken Effexor while pregnant can result in heart defects and other malformations in their child.
Eliquis (apixaban) is a part of a new generation of oral anticoagulants introduced in recent years as a replacement for warfarin. However, side effects of Eliquis have been linked to reports of severe and uncontrollable bleeds, hemorrhages and wrongful death.
Farxiga (dapagliflozin) was introduced by AstraZeneca in 2014 for treatment of type 2 diabetes and has been linked to kidney failure, heart attacks, diabetic ketoacidosis and other types of kidney damage.
Fentanyl is a powerful opiate that works by blocking the pain receptors in the brain. It is sold in several different forms for management of severe and chronic pain. However, if excessive amounts of fentanyl enter the body, there is a serious risk of overdose or death. Fentanyl is also extremely addictive and patients receiving Fentanyl therapy often develop an addiction once treatment has stopped and may turn to other opiates from the street, including heroin.
Proton Pump Inhibitors (PPI) are a class of drugs used for treatment of acid reflux, heartburn, ulcers and other gastroinstestinal problems. Members of this class include popular medications like Nexium, Prilosec, Prevacid, Protonix, AcipHex, Dexilant, Vimovo, Zegerid and others.
Invokana (canagliflozin) was introduced by Johnson & Johnson in March 2013, as a powerful new type II diabetes medication. However, it has been linked to potential life-threatening risks including kidney failure, diabetic ketoacidosis and other kidney problems.
Pfizer’s cholesterol drug Lipitor is one of the most widely used medications in the U.S. Inadequate warnings have been provided about the risk that women may develop diabetes from Lipitor side effects.
The Mirena IUD (Intra-Uterine Device) was introduced by Bayer and approved by the FDA in 2000 as a long-acting form of birth control that is implanted into the uterus. However, many women have suffered severe complications where Mirena IUD perforated the uterus and migrated to other areas of the body.
The NuvaRing is a small and flexible birth control ring, which is designed to be inserted into the vagina once a month. Side effects of NuvaRing may cause women to face an increased risk blood clots when compared to use of some older birth control pills.
Plavix (clopidogrel bisulfate) was approved in 1997 for prevention of blood clots. Lawsuits are being reviewed for people who have taken Plavix and experienced heart attacks, strokes or internal bleeding.
Propecia is a prescription medication used to help reverse male pattern baldness and hair loss. Side effects of Propecia have been linked to a risk of irreversible sexual problems that may persist even after the popular hair loss medication is stopped, including erectile dysfunction, loss of libido and impotence.
Risperdal (risperidone) is an atypical antipsychotic, which has been prescribed to children for bi-polar disorders, autism, irritability, aggression and behavior disorders. Risperdal has a serious side effect in boys that causes male breast growth, also known as Gynecomastia. Johnson & Johnson failed to warn about these serious side effects leaving many children with abnormal breast growth requiring expensive plastic surgery to correct.
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TENS) are severe skin reactions caused as a side effect of several medications. Lawsuits are being investigated for those diagnosed with either of these painful and debilitating conditions.
Taxotere (docetaxel) was introduced by Sanofi-Aventis in 1996 for treatment of metastatic or locally advanced breast cancer along with other chemotherapy drugs. Although chemotherapy is known to cause hair loss, Taxotere warnings fail to indicate that these hair loss problems are often permanent and can lead to Alopecia, where the body’s immune system attacks and kills any new hair follicles, preventing any new hair growth.
Recent studies have suggested that certain users of testosterone replacement therapy may face an increased risk of heart attacks, stroke, blood clots and sudden death. Cases are reviewed for users of prescription “Low T” drugs, including AndroGel, AndroDerm, Textim, Axiron and others.
Topamax, known generically as topiramate, was first introduced in 1979 by McNeil Pharmaceutical, which was approved for treatment of epilepsy and migraine headaches, but are also often prescribed off-label to treat bipolar disorder. Topamax side effects may increase the risk of an unborn child developing an oral cleft or other major birth defects for mothers who has used Topamax during pregnancy.
Tylenol (Acetaminophen) produced by Johnson & Johnson is a over-the-counter pain reliever that has been linked to an increased risk of liver failure, which the manufacturer has allegedly known about for decades.
Viagra (sildenafil citrate) is one of the most widely recognized brand name drugs, used for men experiencing erectile dysfunction. Studies have shown men taking Viagra may face an increased risk of developing melanoma skin cancer.
Xarelto (rivaroxoaban) was introduced in 2011, as an anticoagulant to reduce the risk of stroke, deep vein thrombosis (DVT), pulmonary embolism (PE) and other blood clot injuries. However, side effects of the medication have been linked to reports of uncontrollable bleeding and wrongful death.
Side effects of the popular birth control pills Yaz, Yasmin, Ocella and Gianvi may increase the risk of heart attack, stroke, pulmonary embolism and deep vein thrombosis.
Zofran (ondansetron) is an anti-nausea and vomiting medication that has been prescribed off-label for morning sickness in pregnant women. the drug maker has placed their desire for profits before consumer safety by reckless promoting and encouraging the off-label use of Zofran for morning sickness, while withholding information about the risk of birth defects.
Zoloft, a commonly prescribed anti-depressant has been shown to increase risk of birth defects or malformations in unborn children for mothers who used the SSRI antidepressant Zoloft during pregnancy.
Previously Investigated Drugs:
The drug injury lawyers at Saiontz & Kirk, P.A. previously reviewed and investigated potential claims for users of the following medications. New cases are no longer being accepted for users of these medications at this time, but the following pages are available for informational purposes.